Clinical trial
ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in…
NCT00156923 · Alkermes, Inc., Industry · Completed
Key facts
| NCT number | NCT00156923 |
|---|---|
| Title | ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults |
| Official title | A Multi-Center Extension of Alkermes' Study ALK21-003-EXT (NCT01218971) to Evaluate the Long-Term Safety of Medisorb® Naltrexone |
| Lead sponsor | Alkermes, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | Medisorb naltrexone 380 mg, Medisorb naltrexone 190 mg |
| Enrollment | 108 |
| Start date | Oct 1, 2003 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 11, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: